“…Studies have also examined the impact of ADHD-PRS on outcomes in clinical ADHD samples. Collectively, they suggest that PRS do not just capture risk for ADHD diagnosis but may also be a marker of phenotypic severity in individuals with ADHD, showing association with a wide range of comorbid phenotypes, including CD (Demontis et al, 2021; Hamshere et al, 2013), irritability/emotional dysregulation (Nigg et al, 2020; Riglin et al, 2017), severity of clinical profile (Vuijk et al, 2020), executive function difficulties (working memory, inhibitory control, and response variability) (Chang, Yang, Wang, & Faraone, 2020; Nigg et al, 2018; Vainieri et al, 2021), and SUDs (i.e. alcohol and cannabis use disorders) (Wimberley et al, 2020).…”